PYX Resources: Achieving volume and diversification milestones. Watch the video here.
Finally Tommy admits he is trading this stock.
As suspected previously and noted by myself and many others, the rampers are finding anything to ramp this stock and trading it at the same time, knowing full well it is total garbage.
The science is good, this is where they will ramp it.
The company and staff are totally inept and incapable of bringing this drug to market = interferon beta will never be brought to market by Synairgen.
So, as Tommy said, trade this stock (as he is doing).
Let Tommy and others ramp the stock up (as they keep doing, Belfort style) and then sell and buy back cheaper to make profit. Do NOT get suckered in to thinking this stock is going anywhere though.
Pity Marsden and the other staff at Synairgen completely ruined our trial then.
Had the team knew what they were doing and been able to design and conduct a proper clinical trial (or even outsourced it to another company to design and replicate the P2 results) we would be laughing now.
Sadly not the case, instead we are 90% down and hoping for a takeover at 50p, the cold hard reality.
I’m not saying ‘I told you so’, but in a completely minor way the irony that those who dislike me are now saying exactly what I’ve been saying for the last six months = a breadcrumb of a laugh.
I suppose I am getting the last laugh afterall.
The ‘He’s trying to buy your cheap shares, trying to buy your cheap shares’ brigade (most of whom seem to be missing from the forum these days, obviously were clearly ramping and trading the stock) are either not here or are now also saying that SNG are utterly inept.
Only a few hardcore fans of SNG are still saying that the staff at the company know what they’re doing and will be able to come good.
Give over, they’re a complete pile of garbage and it’s plain to see now.
Minus 6% day.
Was this a bullish Marsden today in the interview (as bullish as Marsden can get)? Otherwise the SP would’ve fallen 20%. I haven’t been able to watch.
So we have 24 million in the bank. How long will that last at paying the wages and fixed costs of the team at Synairgen whilst we wait for platform trials?
A cushty little job for Marsden, 200k a year and a bonus, he deserves his reward at least for todays bullish interview.
Tommy, you’re clutching at straws.
I thought the deep dive data and ACTIV2 P2 was going to give the necessary data for EUA application?
Strange, NRX and Adagio both going for it, based on their P2 data. You were saying Synairgen will too, but now you’re talking about joining on to ACTIV trials?
Two questions:
1. Do you work at the NIH? If not, then why are you discussing this because we are not on those other ACTIV trials.
2. Why are you changing the goalposts? Previously you said that Synairgen can apply for EUA based on P2 and deep dive data. You completely contradict yourself.
Manifesto, if Marsden applies for EUA based on the deep dive data and ACTIV2P2 then he deserves to see this through.
If the data comes back good and he sits on his hands then doesn’t act like we have seen other CEO’s act (Adagio or NRX CEO’s who are bullish and applying for EUA based on their P2 results) then he has to go.
It will show us that whilst Marsden is leading this company it will never achieve commercial success.
The topic of this post = ‘Reality’.
So here is the reality, Synairgen are trying to work two sets of data. They are working their secondary endpoint long covid data and they are also doing a deep dive analysis.
The top line data took months to be released. So if we assume the long covid data will take similar time, add that to the deep diva data. Synairgen are known to be extremely slow so I don’t think that results will come within the next week.
SNG022, even if the chance of EUA is 10% based on deep dive and ACTIV2, Synairgen should still go for it.
That’s 10% higher chance than sitting on their hands and doing FA.
We have seen Lilly get EUA based on P2 results and NRX Pharma have applied for EUA based on their P2 results.
At this stage now I don’t even care about the SP, as we are 87% down. All that matters is that I want to finally see this company actually bloody well do something proactive. Even if they apply for EUA (if they do, the SP will probably double based on an RNS saying they’ve applied for EUA), but the application fails, it doesn’t matter because at least I’ve seen this company try.
So far, I haven’t seen them try to do a frigging thing. It’s taken them a whole year to do a horrendously managed trial with the most ridiculous school boy errors, coupled with the worst communication of any company I’ve ever known.
If they just send out an RNS saying ‘Today we applied for EUA based on our deep dive data analysis that shows people are 40% more likely to survive if given our drug when compared to the best current standard of care’. If they just do this, then I can say ‘FINALLY, finally these useless muppets are doing something’.
From a quick glance at the posts it appears that many on here (funnily enough the ones who dislike me) are actually coming round to what I’ve been saying for the last six months that the team/management at Synairgen is totally useless.
I can state the same thing as I’ve said for months now.
The company is about the people in it, not just about the drug.
If the people in the company are incompetent and utterly inept, it doesn’t matter how long they take, they will never be able to bring this drug to market.
You could give the Pfizer vaccine to the team at Synairgen and they would set up a trial that gives 20% efficacy.
1. They take ages to do anything.
2. They don’t even explain what their next actions are in a detailed way.
3. They have horrendous communication.
4. Whoever writes the RNS’ need to be sacked immediately (probably Marsden).
5. Whoever is in charge of trial design needs to be sacked immediately.
We are better off getting a young and ambitious new CEO in to the picture who has reached senior VP level at a big pharma company, relishes the challenge and can get paid a huge bonus if he/she/they manage to bring this product to market.
One thing is clear as daylight, even if you disagree with me (ironically it seems whilst they will never admit it, there are many on here saying the same thing now), Marsden really has to go.
Marsden has failed in 17 years to bring this drug to market, that is inexcusable for a CEO. It’s now 9 weeks since the worst day in the history of this company and he still hasn’t said a word. What type of a CEO acts like that? Horrendous disrespect to shareholders.
I’m going to give him ONE last benefit of doubt. He can have a look at this deep dive data and P2 of ACTIV.
If the results are good and he sends out a message that this company is applying for EUA based on those results then I would say he can keep his job (for now) because at least it shows he’s trying to get something commercial (which has been his failed job for 17 years).
If the results are rubbish, or they’re good but Synairgen still refuse to apply for EUA (why? NRX pharma have applied for EUA based on P2 data, Lilly were granted EUA based on their P2 data), if he still sits on his hands and says sweet FA as usual, he must go.
Realistically are we expecting SP to drift south for the next few weeks/months until any news comes?
Then if news is positive, could get a 100% increase to around 40p.
If negative, we will get a 50% collapse to around 10p.
A speculative gamble where a new investor can either double their money, or halve it.
All depending on how long of course it takes Synairgen to release some news. Judging from usual form of the company, expect it to be dragged out, so if they said weeks, expect months.
Sharedealer, I’m warning new investors not to get suckered in by the disgusting ramping by sickening rats that are day trading this share.
You are one of the traders on here that tries to lure in new investors with hype and ramps. When you know full well this stock is going nowhere in the next couple of years (because only a total idiot can not see that).
Ramping penny stocks = Jordan Belfort style illegal business for disgusting rats.
Burstead exactly, total scumbags.
Sickening Belfort style rats trying to ramp up this stock despite all the failures of the company.
They can’t ramp the CEO, he’s garbage.
They can’t ramp the trial results, it’s garbage.
They can’t ramp the SP, it’s crashed 90%.
They can’t ramp ACTIV as it’s been halted.
They can’t ramp the coms, they’re useless.
They can’t ramp a thing to do with this company at all because it’s failed in 20 years to bring a single drug to market.
Instead they talk about how interferon works and they say how terrible covid is becoming. Yeah, that might be the case, but it means sweet FA for Synairgen because Synairgen don’t have a drug on the market and never will.
No insane rants at all.
Simply warning any new investors of this hype train.
I repeat again, if the rampers on here were brokers they would be in prison now.
Disgusting rats trying to pump up this failing garbage company so they can day trade the stock. Sickening leeches.
I will continue to warn new investors on here.
I think it is utterly sickening that rampers get away with what they do without ramifications of the FCA.
Sickening rats trading this stock whilst luring in new investors when all the evidence shows this company is going nowhere for at least a couple of years.
Ramp up the failing penny stock to lure in new investors so that they can trade the stock at the new investors expense.
Disgusting rats.
If the rampers actually worked in finance, they’d be in prison.
Pathetic weak versions of Jordan Belfort.
NEW INVESTORS, you see, they do not want you to see what I write because they want you to believe their ramping.
I repeat, if they worked in finance THEY WOULD BE IN PRISON NOW.
Jordan Belfort and others, ramping penny stocks up to day trade them is disgusting. So are these people.
These people are all underwater with this useless company and yet they are ramping the stock up, when it hasn’t gone to market in 20 years.
When they know someone is right they try to shut them down because they know that if this stock isn’t ramped then they can not make any money.
Please, do your due diligence before being suckered in to investing in this hype train.
It’s not true.
It’s an attempt to ramp the stock so that the usual mob can trade it.
Jordan Belfort style ramping in order to sucker in new investors and make profits.
How has ‘detective AIM’ predictions gone so far with Synairgen? The SP is 90% down, did he predict that?
The same sick rats that posted all over the Synairgen tweets about making money and ‘stocks about to explode’ when Synairgen were making one of their tweets about saving lives.
F11cking disgusting ramping rats. If they worked in finance they’d be in prison now.
Wait for them all to jump on.
Why?
BECAUSE I’M RIGHT.
I repeat, any Jordan Belfort style rampers on here would be in PRISON now, if they actually worked in finance.
They hate me because I am warning new investors of their games.
Very simple:
They want to lure in new investors (Belfort style) to make a daily/weekly profit and then dump their shares.
This is the game with this stock. The company has been proven to be rubbish, all you have to do is look at the total embarrassment their SPRINTER trial has been.
Companies that are the laughing stock of the pharma world do not end up being successful.